Research Archive — Page 49 of 134
-
January 9, 2023
Novel lung cancer biomarker
Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer. -
January 6, 2023
Early effects of Huntington disease
Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials. -
January 6, 2023
MicroRNAs linked to lipid damage
VUMC researchers have linked microRNAs with systemic lipid peroxidation, a discovery that could point to new therapeutic targets for a variety of diseases. -
January 5, 2023
VUMC researchers upend dogma about vasopressin production
Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney. -
December 28, 2022
Vanderbilt mourns loss of renowned scientist Exton
John H. Exton, MBChB, MD, PhD, professor of Molecular Physiology and Biophysics, emeritus at Vanderbilt University, whose research provided fundamental insights into how many biologically active compounds control cellular physiology, died Dec. 18. He was 89. -
December 16, 2022
VUMC Announces VICTR Leadership Transition
-
December 15, 2022
Novel therapeutic target identified for chronic kidney disease
Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.